Home
Live Updates
Double Take: This Singapore Healthtech Startup Develops Digital Twins To Manage Chronic Diseases : vimarsana.com
Double Take: This Singapore Healthtech Startup Develops 'Digital Twins' To Manage Chronic Diseases
Mesh Bio on Wednesday raised $3.5 million in funding to double down on its digital twin technology, which produce virtual models, or “twins,” of a patient’s state of health based on their data.
Related Keywords
Apis ,
Northern Samar ,
Philippines ,
Hong Kong ,
Indonesia ,
Singapore ,
Willson Cuaca ,
Andrew Wu ,
Forbes Asia ,
University College London ,
Singapore Health Sciences Authority ,
World Health Organization ,
Mesh Bio ,
East Ventures ,
Health Sciences Authority ,
Healthvector Diabetes ,
University College ,
Southeast Asia ,
Kong Based Gense Technologies ,
Digital Health ,
Digital Health Care ,
Chronic Disease ,
Chronic Disease Management ,
Diabetes ,
Type 2 Diabetes ,
Singapore Startup ,
Healthcare Startup ,
Singapore Unicorn ,
Dai Health ,
vimarsana.com © 2020. All Rights Reserved.